Cargando…
Prevention of post-ERCP pancreatitis: NSAID or pancreatic stent or both?
Autores principales: | van Wanrooij, R. L. J., van Hooft, J. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609235/ https://www.ncbi.nlm.nih.gov/pubmed/31288260 http://dx.doi.org/10.1055/a-0889-7796 |
Ejemplares similares
-
Post-ERCP Pancreatitis: Risk factors and role of NSAIDs in primary prophylaxis
por: Nawaz, Muhammad Haseeb, et al.
Publicado: (2020) -
Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
por: Phillip, Veit, et al.
Publicado: (2019) -
Prevention of Post-ERCP Pancreatitis
por: Donnellan, F., et al.
Publicado: (2012) -
Underutilization of prophylactic rectal indomethacin and pancreatic duct stent for prevention of post-ERCP Pancreatitis
por: Issak, Abdulfatah, et al.
Publicado: (2021) -
The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study
por: Zhang, Cheng, et al.
Publicado: (2017)